This site is intended for Healthcare professionals only.

USFDA completed audit of Mexican plant: Dr Reddy’s Laboratories

USFDA completed audit of Mexican plant: Dr Reddy’s Laboratories

New Delhi: Drug major Dr Reddy’s Laboratories on Friday said the US health regulator has completed audit of its API Cuernavaca Plant in Mexico.

“The audit of our API Cuernavaca plant in Mexico by the USFDA has been completed with zero observations,” Dr Reddy’s Laboratories (DRL) said in a BSE filing.

The stock was trading 0.96 per cent lower at Rs 447 on the BSE.

READ  Natco Pharma seeks USFDA approval for hepatitis drug


Source: PTI
0 comment(s) on USFDA completed audit of Mexican plant: Dr Reddy’s Laboratories

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted